Article
Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma
20 Jul 2020
Abstract excerpt
Neuroblastoma is the most common paediatric cancer type. Patients diagnosed with high-risk neuroblastoma have poor prognosis and occasionally tumours relapse. As a result, novel treatment strategies are needed for relapse and refractory neuroblastoma patients. Here, we found that high expression of Mps1 kinase (mitotic kinase Monopolar Spindle 1) was associated with relapse-free neuroblastoma patient outcomes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
